ArticleThe Journal of experimental medicine2014

CX₃CL1 (fractalkine) and its receptor CX₃CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin.

Delphine Staumont-Sallé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.